These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9928755)

  • 1. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
    Isles CG; Kitchin NR
    J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
    Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
    Conlin PR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
    J Hum Hypertens; 1998 Oct; 12(10):693-9. PubMed ID: 9819017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group.
    Glasser SP; Ripa SR; Allenby KS; Schwartz LA; Commins BM; Jungerwirth S
    Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg.
    Toal CB;
    Clin Ther; 2001 Jan; 23(1):87-96. PubMed ID: 11219482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group.
    Zidek W; Spiecker C; Knaup G; Steindl L; Breuer HW
    Clin Ther; 1995; 17(4):686-700. PubMed ID: 8565032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.
    Ueng KC; Ningling S; El Maksod A; Hung KY; Yuehui Y
    Clin Drug Investig; 2011; 31(9):631-42. PubMed ID: 21591818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
    Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
    Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
    Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Mancia G; Omboni S; Parati G;
    J Hypertens; 2002 Mar; 20(3):545-53. PubMed ID: 11875324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group.
    Zanchetti A
    Drugs; 1994; 48 Suppl 1():23-30; discussion 30-1. PubMed ID: 7533703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses.
    Kjeldsen SE; Cha G; Villa G; Mancia G;
    J Clin Pharmacol; 2016 Sep; 56(9):1120-9. PubMed ID: 26829251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
    Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
    Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.